UCL Cancer Institute


Department of Clinical Trials

Head of Department: Professor Jonathan Ledermann
Professor of Medical Oncology

Cancer Research UK & UCL Cancer Trials Centre (CTC)

Director: Professor Jonathan Ledermann
Deputy Director: Professor Allan Hackshaw
The Cancer Research UK and UCL Cancer Trials Centre forms the Clinical Trials research department within UCL Cancer Institute and is part of the Cancer Research UK-UCL Centre. The CTC is one of the nine accredited clinical trials units of the National Cancer Research Institute. The CTC coordinates national and international cancer trials.

The Cancer Trials Centre has five key aims:

  •     To develop and conduct high quality trials to change clinical practice
  •     To evaluate new ways of treating or detecting a wide variety of cancers using multi-modal approaches
  •     To foster national and international collaboration with other researchers in cancer
  •     To translate laboratory innovations into clinical trials and generate new scientific ideas
  •     To train a new generation of cancer clinical trials specialists


UCLH/UCL Clinical Research Facility

A collaboration between UCL and University College London Hospitals Foundation Trust (UCLH), the Clinical Research Facility accommodates early phase clinical trials of new anti-cancer drugs and treatments. This service is split between clinical areas in the UCLH/UCL Clinical Research Facility (UCLH/UCL CRF) based in the Elizabeth Garrett Anderson Wing of University College Hospital and laboratory space within the UCL Cancer Institute. It aims to provide a safe and efficient setting in which research can be conducted as rapidly and effectively as possible, so that new drugs and treatments for cancer can reach patients more quickly.

The UCLH/UCL Clinical Research Facility conducts early phase trials jointly with UCL Hospitals and the Sarah Cannon Research Institute (SCRI) in London.